v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Other Comprehensive Loss
Retained Earnings
Beginning balance (in shares) at Jun. 30, 2024   1,303,769        
Beginning balance at Jun. 30, 2024 $ 8,539,454 $ 1,304 $ 8,223,046 $ (24,365,783) $ (130,428) $ 24,811,315
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock (in shares)   3,990        
Issuance of common stock 1,756 $ 4 1,752      
Purchase of treasury stock (in shares)   (25,964)        
Purchase of treasury stock (2,095,540) $ (26)   (2,095,514)    
Reissuance of treasury stock (in shares)   1,162        
Reissuance of treasury stock 60,557 $ 1 55,124 5,432    
Equity-based compensation expense 249,085   249,085      
Net income 3,638,129         3,638,129
Other comprehensive loss 6,517       6,517  
Cash dividends declared (888,853)         (888,853)
Ending balance (in shares) at Mar. 30, 2025   1,282,957        
Ending balance at Mar. 30, 2025 9,511,105 $ 1,283 8,529,007 (26,455,865) (123,911) 27,560,591
Beginning balance (in shares) at Dec. 29, 2024   1,284,956        
Beginning balance at Dec. 29, 2024 8,808,026 $ 1,285 8,439,903 (26,024,098) (134,085) 26,525,021
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock (in shares)   3,558        
Issuance of common stock 1,993 $ 4 1,989      
Purchase of treasury stock (in shares)   (5,557)        
Purchase of treasury stock (431,773) $ (6)   (431,767)    
Equity-based compensation expense 87,115   87,115      
Net income 1,330,667         1,330,667
Other comprehensive loss 10,174       10,174  
Cash dividends declared (295,097)         (295,097)
Ending balance (in shares) at Mar. 30, 2025   1,282,957        
Ending balance at Mar. 30, 2025 $ 9,511,105 $ 1,283 8,529,007 (26,455,865) (123,911) 27,560,591
Beginning balance (in shares) at Jun. 29, 2025 1,268,740 1,268,740        
Beginning balance at Jun. 29, 2025 $ 9,861,619 [1] $ 1,268 8,697,290 (27,763,430) (62,423) 28,988,914
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock (in shares)   4,882        
Issuance of common stock 13,021 $ 6 13,015      
Purchase of treasury stock (in shares)   (24,185)        
Purchase of treasury stock (3,589,933) $ (24)   (3,589,909)    
Reissuance of treasury stock (in shares)   1,102        
Reissuance of treasury stock 67,185 $ 1 61,516 5,668    
Equity-based compensation expense 282,396   282,396      
Net income 4,988,114         4,988,114
Other comprehensive loss (58,969)       (58,969)  
Cash dividends declared $ (978,654)         (978,654)
Ending balance (in shares) at Mar. 29, 2026 1,250,539 1,250,539        
Ending balance at Mar. 29, 2026 $ 10,584,779 $ 1,251 9,054,217 (31,347,671) (121,392) 32,998,374
Beginning balance (in shares) at Dec. 28, 2025   1,251,180        
Beginning balance at Dec. 28, 2025 10,145,426 $ 1,251 8,948,439 (30,203,796) (98,701) 31,498,233
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock (in shares)   4,362        
Issuance of common stock 9,167 $ 5 9,162      
Purchase of treasury stock (in shares)   (5,003)        
Purchase of treasury stock (1,143,880) $ (5)   (1,143,875)    
Equity-based compensation expense 96,616   96,616      
Net income 1,825,460         1,825,460
Other comprehensive loss (22,691)       (22,691)  
Cash dividends declared $ (325,319)         (325,319)
Ending balance (in shares) at Mar. 29, 2026 1,250,539 1,250,539        
Ending balance at Mar. 29, 2026 $ 10,584,779 $ 1,251 $ 9,054,217 $ (31,347,671) $ (121,392) $ 32,998,374
[1] Derived from audited financial statements